Image for New publication by Gradientech and Uppsala University on rapid AST platform
2020-02-26

New publication by Gradientech and Uppsala University on rapid AST platform

Uppsala, February 26, 2020. Gradientech today announces the scientific publication of a navel multiplex fluidic chip for rapid antibiotic susceptibility testing (ASn. The chip can generate AST results within 2-4 ho urs, which is at least 20 hours faster than current AST methods used in hospital laboratories.

There is an unmet need for faster and more precise AST methods that can determine which antibiotics will be mast effective against a bacterial infection in a timely man ner. This is particularly important for time-critical conditions like sepsis, where every minute without appropriate treatment reduces the chance of survival.

The results obtained with the multiplex fluidic chip serve as a proof-of-concept for the commercial QuickMIC® AST system that Gradientech is currently developing, which is based on the same proprietary technology. This rapid AST technology has the potential to enable faster and targeted treatment initiation in sepsis patients, thereby contributing to improved clinical outcomes, reduced healthcare costs and help in the fight against antibiotic resistance.

The study findings have been published in mBio, a prestigious open access journal from the American Society for Microbiology. To access the full article, follow the link below:

https://mbio.asm.org/content/11/1/e03109-19

For further information, please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80
sara.thorslund@gradientech.se

Gradientech is an ISO13485 certified company since 2017

Contact

Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala
Sweden

sales@gradientech.se

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book